Correction to: Cancer Immunology, Immunotherapy https://doi.org/10.1007/s00262-023-03546-9
The original version of this article unfortunately contained few mistakes in figure 6. An overlap in the figures representing CD45 of the high ICI group as well as in the Figures representing CD3 of the low ICI group.
The corrected figure 6 is provided in the next page.
mICIS has yielded evidence that the anti-tumor efficacy of T cells infiltrating HCC was separated from their mere existence within the tumor microenvironment. The expression levels of CD45, CD3, CD4, and CD8 were analyzed in patients diagnosed with HCC, and subsequently categorized into high and low score groups (n = 3). HCC, hepatocellular carcinoma; mICIS, modified immune cell infiltration score. Mean ± SD. Statistical significance determined by paired two-tailed t-test. **P < 0.01
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pan, B., Luo, Y., Ye, D. et al. Correction to: A modified immune cell infiltration score achieves ideal stratification for CD8+ T cell efficacy and immunotherapy benefit in hepatocellular carcinoma. Cancer Immunol Immunother 72, 4121–4122 (2023). https://doi.org/10.1007/s00262-023-03576-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-023-03576-3